Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy

Pyrazinamide induced morbilliform rash: cutaneous complications in anti-tubercular therapy

Bibliographic Details
Main Author:	Shatavisa Mukherjee
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	MGM Journal of Medical Sciences
Online Access:	http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=2;spage=258;epage=259;aulast=Mukherjee

Similar Items

Morbilliform rash.
by: Furness, C, et al.
Published: (2004)

10-minute consultation Morbilliform rash
Published: (2004)

Pyrazinamide-induced maculopapular rash
by: Khayyam Khalid, et al.
Published: (2010-01-01)

Morbilliform rashes as an unusual manifestation of vaccine-induced immune thrombotic thrombocytopenia
by: Wan-Ting Yang, et al.
Published: (2022-06-01)

Cutaneous mantle cell lymphoma presenting as a diffuse morbilliform rash: A case report
by: Spencer Tuohy, et al.
Published: (2023-11-01)

Mpox infection presenting with morbilliform rash: A case series
by: Erin Bartholomew, BA, et al.
Published: (2023-05-01)

Morbilliform skin rash with prominent involvement of the palms in Chikungunya fever
by: Maria Laura Tini, et al.
Published: (2018-01-01)

Rapidly progressive neurologic decline and morbilliform rash presenting in a patient with lymphoma
by: Dean Ehrlich, et al.
Published: (2018-12-01)

Florid cutaneous morbilliform eruption in the setting of primary Epstein-Barr virus infection
by: Shahin A. Saberi, BS, et al.
Published: (2024-03-01)

An asymmetric morbilliform eruption in an adult male
by: Allyson Yelich, DO, et al.
Published: (2023-01-01)

Unfamiliar manifestations of anti-tubercular therapy
by: Ramesh Aggarwal, et al.
Published: (2014-01-01)

Jaundice and morbilliform eruption in a 20-year-old female
by: Bianca Biglione, BS, et al.
Published: (2023-01-01)

Imatinib mesylate-induced cutaneous rash masquerading as pityriasis rosea of Gilbert
by: Prashant Verma, et al.
Published: (2014-01-01)

The immune response in tubercular uveitis and its implications for treatment: from anti-tubercular treatment to host-directed therapies
by: Putera, Ikhwanuliman, et al.
Published: (2024)

A study on comparative efficacy of anti tubercular chemoprophylaxis with 2 different regimens: 2 months of rifampicin and pyrazinamide and 6 months of daily isoniazid and rifampicin in HIV infected tuberculin reactors
by: Prasad BNBM
Published: (2006-01-01)

Role of Nigella Sativa Seeds on Pyrazinamide Induced Hepatotoxicity
by: Amtul Hafeez , Akbar Waheed , Neelofar Yousaf
Published: (2019-03-01)

A case of cutaneous metastasis mimicking herpes zoster rash
by: Angela Chiang, et al.
Published: (2018-01-01)

Cerebral venous thrombosis (CVT) complicating tubercular meningitis
by: Qian Li, et al.
Published: (2023-06-01)

Post tubercular gastropulmonary fistula: A rare complication
by: Dheeraj Sharma, et al.
Published: (2016-04-01)

An approach toward cutaneous granulomatous lesion: A retrospective analysis in a tertiary care setup
by: Mala Mukherjee, et al.
Published: (2022-01-01)

Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis
by: Shiyang Zhou, et al.
Published: (2017-01-01)

Amoxicillin Morbilliform Drug Eruption in Pediatric Male with Poor Feeding Treated with Cyproheptadine: A Case Report
by: Daniel Nguyen, et al.
Published: (2018-08-01)

Minocycline induced drug rash with eosinophilia and systemic symptoms complicated by hemophagocytic lymphohistiocytosis
by: Raymond Zhao, BS, et al.
Published: (2023-02-01)

Pyrazinamide-induced phototoxicity: A case report and review of literature
by: Katiyar Subodh, et al.
Published: (2010-01-01)

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
by: Shulan Dong, et al.
Published: (2024-01-01)

Multifocal Tubercular Dactilytis of Feet with Tubercular Ulcers
by: Aditi Jha, et al.
Published: (2016-06-01)

Clinical Significance of Preoperative Pyrazinamide-Containing Therapy in Tuberculous Constrictive Pericarditis
by: Fang L, et al.
Published: (2024-01-01)

Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide
by: Stefanie Krug, et al.
Published: (2023-12-01)

Ibrutinib-Induced Skin Rash
by: Sudhir Kirar, et al.
Published: (2021-02-01)

Carbamazepine-Induced Skin Rash
by: J Gordon Millichap
Published: (1993-07-01)

Photosensitive rash induced by nivolumab
by: Francisco J. Navarro-Triviño, et al.
Published: (2022-09-01)

Aripiprazole-induced skin rash
by: Santanu Nath, et al.
Published: (2016-01-01)

Pyrazinamide resistance in rifampicin discordant tuberculosis.
by: Nomonde Ritta Mvelase, et al.
Published: (2022-01-01)

Pyrazinamide resistance in rifampicin discordant tuberculosis
by: Nomonde Ritta Mvelase, et al.
Published: (2022-01-01)

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

Ethambutol optic neuropathy in the extended anti-tubercular therapy regime: A systematic review
by: Swapnali Sabhapandit, et al.
Published: (2023-01-01)

Rowell syndrome secondary to anti-tubercular therapy: A case report and literature review
by: Bibush Amatya, et al.
Published: (2017-04-01)

Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis
by: P K Debnath, et al.
Published: (2012-01-01)

Tubercular Subdural Empyema with Tubercular Abscess: Lessons Learnt
by: Rajkumar Pannem, et al.
Published: (2023-12-01)

Coexistence of tubercular constrictive pericarditis with tubercular pleural effusion
by: Amol Andhale, et al.
Published: (2023-01-01)